Estrogen deprivation or tamoxifen cause activation of Notch1 in ER-positive breast cancer cells, and Notch inhibition dramatically increased the efficacy of tamoxifen in MCF-7 xenografts, causing tumor regression [10]. Here, NOTCH1 is linked to breast cancer.